Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJ0113 in Depressive Disorder
NCT07018245Phase 2Completed
- Sponsor
- Phecda Medicine
- Start
- Jul 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TJ0113 in major depressive disorder (MDD), sponsored by Phecda Medicine. Started Jul 2025; status: completed.
02
Drugs
TJ0113
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07018245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07018245.